DexCom, Inc. specializes in the development, manufacture, and distribution of continuous glucose monitoring systems for diabetes management. Its products are designed to help patients control their diabetes by tracking glucose levels in real-time.
The company was founded in 1999 and is headquartered in San Diego, California, United States. It has revolutionized diabetes care with its innovative glucose monitoring technology.
DexCom's primary product is the continuous glucose monitoring (CGM) system, which includes a sensor for detecting glucose levels, a transmitter that sends data to a display device, and a receiver or compatible smart device that displays glucose information.
|Mr. Kevin Ronald Sayer
|Executive Chairman, CEO & President
|Mr. Jereme M. Sylvain
|Executive VP, CFO & Chief Accounting Officer
|Mr. Jacob Steven Leach
|Executive VP & COO
|Mr. Girish Naganathan
|Executive VP & CTO
|Mr. Michael Jon Brown
|Executive VP & Chief Legal Officer
|Mr. Shelly Ramasamy Selvaraj
|Senior VP & Chief Information Officer
|Mr. Sean Christensen
|Director of Corporate Affairs & Head of Investor Relations
|Mr. Matthew Dolan
|Executive Vice President of Strategy, Corporate Development & Dexcom Labs
|Ms. Sadie M. Stern
|Executive VP & Chief Human Resources Officer
|Mr. Steven R. Pacelli
|Executive VP & MD of Dexcom Ventures